Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration ...
Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating ERLEADA® without docetaxel ...
A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...
A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...
Hosted on MSN
High-tech laser prostate reduction operations now being delivered in Northants as a day case
Patients say the difference it makes is amazing. A state-of-the-art laser prostate reduction operation is now being successfully delivered in the county as a day case procedure. HOLEP, or Holmium ...
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...
Prostate Cancer Straight Talk led by Jersey City Library Executive Director Terry Hill, boost early screening and support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results